Europe · Markets & Finance · Challenges

Aujourd’hui, soigner son asthme pollue, mais la pharma investit des millions en France pour produire des inhalateurs bas carbone

Published by Challenges · France 5 h ago

Pressés par la réglementation européenne, trois laboratoires ont choisi la France pour fabriquer une nouvelle génération d’inhalateurs médicaux qui n’aggravent plus le…

Read the full article on Challenges Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.challenges.fr)

Also worth reading

City A.M.

Burnham to clamp down on ‘unfair’ non-compete clauses

This is Money

Bank of England chief warns Healey: Balance the books or face a bond market storm

Financial Times

SoftBank seeks $100bn from Gulf investors to expand AI bet

FXStreet

Silver Price Forecast: XAG/USD regains ground amid a pullback in US Treasury Yields

Reuters Markets

Morning Bid: Feeding the AI beast

Reuters Sustainability